<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-pharmaceuticals-12-00157">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Warfield</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Warren</surname>
    <given-names>T.K.</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wells</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mire</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Geisbert</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Stuthman</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Garza</surname>
    <given-names>N.L.</given-names>
   </name>
   <name>
    <surname>Van Tongeren</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Shurtleff</surname>
    <given-names>A.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>138</volume>
  <fpage>22</fpage>
  <lpage>31</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.019</pub-id>
  <pub-id pub-id-type="pmid">27908828</pub-id>
 </element-citation>
</ref>
